FDA DEVICE FACTS
eXaSkin Plus
Anatomical Geometry S.L.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
eXaSkin is a radiotherapy bolus for treatment of neoplastic skin lesions. Qualified healthcare professionals apply it to the irradiated area to address anatomical irregularities and ensure precise delivery of the prescribed dose to skin and underlying tissues during radiation therapy. It was evaluated with 6 MV photons but has not been assessed with 10 MV photons, protons, or orthovoltage X-rays. eXaSkin Plus 150 and 225 are intended for general radiotherapy use; eXaSkin Plus 650 is intended for breast tissue.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。